p53 siRNA (m), shRNA and Lentiviral Particle Gene Silencers | SCBT - Santa Cruz Biotechnology
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
Time-dependent p53 inhibition determines senescence attenuation and long-term outcome after renal ischemia-reperfusion | American Journal of Physiology-Renal Physiology
Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy | Nature Communications
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome | Nature Communications
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer - ScienceDirect
Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities | Nature Communications
Temporary and reversible induction of p53.1224 shRNA protects mice... | Download Scientific Diagram
Inducible Gene and shRNA Expression in Resident Hematopoietic Stem Cells In Vivo - Laurenti - 2010 - STEM CELLS - Wiley Online Library
Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode | Nature
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program - ScienceDirect
Knockdown of p53 using siRNA and its effect on mouse ESC proliferation.... | Download Scientific Diagram
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer - ScienceDirect
Ferroptosis as a p53-mediated activity during tumour suppression | Nature
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program - ScienceDirect
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion - ScienceDirect
Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion
Loss of TP53 mediates suppression of Macrophage Effector Function via Extracellular Vesicles and PDL1 towards Resistance against Chemoimmunotherapy in B-cell malignancies | bioRxiv
US8906874B2 - Bi-functional shRNA targeting Stathmin 1 and uses thereof - Google Patents
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer - ScienceDirect
